HealthEquity, Inc.

As of October 10, 2025, HealthEquity, Inc. shows a bearish technical trend with underperformance compared to the S&P 500, having a year-to-date return of -5.66% versus the S&P's 11.41%.

As of October 10, 2025, HealthEquity, Inc. is in a bearish trend with moderate strength, underperforming the S&P 500 year-to-date with a return of -5.66% compared to the S&P 500's 11.41%.

As of October 3, 2025, HealthEquity, Inc. has a bearish trend with moderate strength, indicated by bearish signals from the weekly MACD and Bollinger Bands, and has underperformed the S&P 500 with a year-to-date return of -8.51%.

As of October 3, 2025, HealthEquity, Inc. is in a bearish trend with moderate strength, underperforming the S&P 500 year-to-date with a return of -7.67% compared to the index's 14.18%.

As of October 3, 2025, HealthEquity, Inc. has a bearish outlook due to negative technical indicators and underperformance compared to the S&P 500, with a year-to-date return of -7.67% versus the index's 14.18%.

As of September 5, 2025, HealthEquity, Inc. shows a bearish trend with negative momentum indicators, despite recent outperformance against the S&P 500 over the past week and month, while underperforming year-to-date and over longer periods.

As of September 2, 2025, HealthEquity, Inc. is considered very expensive with a high P/E ratio of 53 and poor long-term performance compared to the S&P 500, indicating it may be overvalued relative to its peers.

As of June 16, 2025, HealthEquity, Inc. is considered very expensive and overvalued with a P/E ratio of 53, significantly higher than its peers, indicating that its recent performance may not be sustainable.

As of June 18, 2025, the market trend has shifted to bullish, supported by strong indicators such as bullish MACD and moving averages, positive Bollinger Bands, and a 1-year return of 21.01% compared to the S&P 500's 10.26%.

As of March 2022, the management team of HealthEquity, Inc. includes Robert Selander (Chairman), Jon Kessler (CEO), Stephen Neeleman (Vice Chairman), and several independent directors: Frank Corvino, Adrian Dillon, Evelyn Dilsaver, Debra McCowan, and Stuart Parker. They oversee the company's strategic direction and operations.

HealthEquity, Inc. provides solutions for managing healthcare accounts and operates in the Capital Markets industry, with a market capitalization of approximately $8.65 billion. As of April 2025, it reported net sales of $331 million and a net profit of $54 million.

As of Jun 18, HealthEquity, Inc. has a market capitalization of $8.65 billion, with net sales of $1.24 billion and a net profit of $121.79 million over the latest four quarters. The balance sheet shows shareholder's funds of $2.11 billion and total assets of $3.54 billion.